Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is increasingly widespread with an overall global estimated prevalence of 25%. Type 2 diabetes Mellitus (T2DM) is a key contributor to NAFLD progression and predicts moderate-severe liver fibrosis and mortality. However, there is currently no uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kaina, Sng, Wei Kwan, Quah, Joanne Hui-Min, Liu, Jin, Chong, Bee Yen, Lee, Hwee Khim, Wang, Xue Fei, Tan, Ngiap Chuan, Chang, Pik-Eu, Tan, Hong Chang, Bee, Yong Mong, Goh, George Boon Bee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446805/
https://www.ncbi.nlm.nih.gov/pubmed/32822391
http://dx.doi.org/10.1371/journal.pone.0236977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446805/
https://www.ncbi.nlm.nih.gov/pubmed/32822391
http://dx.doi.org/10.1371/journal.pone.0236977

Ejemplares similares